Guideline Profile : Psoriatic arthritis

You are here : Home > Formulary Search > Guideline Profile : Psoriatic arthritis

Documentation

Guidelines (Local)

Psoriatic Arthritis Immunomodulator pathway SERMOG 09.pdf

Drugs

Below are listed all drugs that are used to treat Psoriatic arthritis.

Committee Recommendations (1)

03 Sep 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee has agreed SERMOG-09 high-cost immunomodulatory drugs for psoriatic arthritis.

Guideline Profile

Indication :

Psoriatic arthritis

Keywords :

adalimumab, infliximab, etanercept, certolizumab, golimumab, ustekinumab, secukinumab, bimekizumab, ixekizumab, guselkumab, risankizumab, apremilast, tofacitinib, upadacitinib,

Brand Names Include :

Humira, Amgevita, Hyrimoz, Hulio, Imraldi, Yuflyma, Idacio, Remicade, Inflectra, Remsima, Flixabi, Zessly, Enbrel, Benepali, Erelzi, Cimzia, Simponi, Stelara, Uzpruvo, Pyzchiva, Wezenla, Steqeyma, Imuldosa, Cosentyx, Bimzelx, Taltz, Tremfya, Skyrizi, Otelza, Xeljanz, Rinvoq

Important Information :

Latest Additions Date From :

Latest Additions Date To :

Supporting Documents :